Variability in agitated saline echocardiography protocols: a cross-sectional analysis of bubble study techniques in echo labs across Alberta, Canada

Canadian Journal of Physiology and Pharmacology · Published 2026-01-01 · DOI 10.1139/cjpp-2025-0326

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1139/cjpp-2025-0326

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Interplay between cardiomyocytes and nonmyocytes plays a vital role in cardiac metabolism and function: early-phase metabolic syndrome and short QT · Canadian Journal of Physiology and Pharmacology · 2025 · Same journal
• Association of stromal cell-derived factor 1α and interferon-γ-induced protein 10 with Fontan pathophysiology · Canadian Journal of Physiology and Pharmacology · 2026 · Same journal
• Cost-effectiveness of incretin therapies: a Canadian lens on diabetes, obesity, and emerging indications · Canadian Journal of Physiology and Pharmacology · 2026 · Same journal
• Protective effects of Melissa officinalis ethanolic extract on doxorubicin-induced cardiotoxicity in a rat model · Canadian Journal of Physiology and Pharmacology · 2025 · Same journal
• Placental hypoxia and oxidative stress responses to smokeless tobacco use in Alaska Native participants in the MAW study · Canadian Journal of Physiology and Pharmacology · 2026 · Same journal
• Redox homeostasis and therapeutic modulation: the central role of oxidative stress and nuclear factor erythroid 2-related factor 2 (Nrf2) activation in systemic diseases and reproductive dysfunction · Canadian Journal of Physiology and Pharmacology · 2025 · Same journal
• The transplacental transfer of NHC, the active metabolite of molnupiravir, in the ex vivo human placental perfusion model · Canadian Journal of Physiology and Pharmacology · 2026 · Same journal
• THE ASSOCIATION OF ARTERIAL STIFFNESS WITH THE HIGH INCIDENCE OF CARDIAC ARRHYTHMIAS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE · Canadian Journal of Physiology and Pharmacology · 2026 · Same journal
• Deferoxamine alleviates brain ischemia/reperfusion injury through decreasing LAG-3 and α-Syn expression · Canadian Journal of Physiology and Pharmacology · 2025 · Same journal
• Metabolic therapy for cardiovascular diseases with propionyl L-carnitine · Canadian Journal of Physiology and Pharmacology · 2026 · Same journal